Hyperglucagonaemia and treatment with danazol for systemic lupus erythematosus.
نویسنده
چکیده
The patient's temperature fell to 36'C in the first 20 hours but then fluctuated up to 38'C for five days. Further doses of quinine every 12 hours (maximum 12-2 mg/kg daily) steadily reduced the parasitaemia to zero in six days. The therapeutic concentration of plasma quinine ranged between 10-3 and 25-6 mmol/l (3 and 8 isg/ml). Six doses were given intravenously (two were only 250 mg), then 14 by mnouth for a total of 9500 mg over nine days, followed by a single dose of 75 mg pyrimethamine and 1500 mg sulfadoxine (three tablets of Fansidar). She became confused on day 7 and her haemoglobin concentration had fallen to 57 g/l by day 10. A 4 unit blood transfusion raised the.haemoglobin value to 117 g/l and rapidly restored her mental state to normal. Blood films remained negative on days 17, 24, 38, and 66.
منابع مشابه
Danazol in treatment of lupus thrombocytopenia.
Seven patients with systemic lupus erythematosus (SLE), persistent thrombocytopenia (TP), in whom it was considered undesirable to institute an increase in steroid or immunosuppressive agents, were treated with danazol. Five patients completed the minimum period of 8 weeks. Two patients showed early response to danazol but were switched over to cyclophosphamide or azathioprine after 4 weeks bec...
متن کاملTreatment of Systemic Lupus Erythematosus in a 44-year-old Female Patient according to Iranian Traditional Medicine in Bojnurd
Background: Systemic Lupus Erythematosus is a kind of multi-system autoimmune disorder with unknown aetiology and it produces antibodies against various tissues. Case Presentation:The patient wasa 44-year-old woman with a history of Systemic Lupus Erythematosus for approximately five years, along with underlying diseases including peptic ulcers, asthma, h...
متن کاملAssociation of Macrophage Activating Syndrome with Castleman’s Syndrome in Systemic Lupus Erythematosus
Macrophage Activating Syndrome (MAS) is a life-threatening disease seen in autoimmune diseases including lupus erythematosus, rheumatoid arthritis, Still's disease, polyarteritis nodosa. It is characterized by fever, pancytopenia, liver failure, coagulopathy, and neurologic symptoms and high serum ferritin. A 27 yr. old female patient was admitted in shahid Mostafa Khomeini Hospital (Tehran-Ira...
متن کاملSurvival rate of patients with systemic Lupus Erythematosus
Background: Due to infections, cardio-vascular involvement and renal insufficiency, patients with systemic lupus erythematosus live shorter than usual. Objective: To determine the mean survival rate of SLE patients. Patients and Methods: 62 SLE patients admitted in the hospitals of Kerman University of Medical Sciences from 1369 to 1380 were included in this study. The demographic variabl...
متن کاملCodon 72 Polymorphism of p53 Gene and Hematologic Manifestations in Patients with Systemic Lupus Erythematosus
Background: Systemic lupus erythematosus is a systemic autoimmune disorder with unclear etiology. The importance of some genes in the development of systemic lupus erythematosus has been implicated. The gene polymorphism in codon 72 has attracted a lot of attention and its role in the occurrence or progression of many cancers and autoimmune diseases especially systemic lupus erythematosus has ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- British medical journal
دوره 291 6503 شماره
صفحات -
تاریخ انتشار 1985